Interviews

DirectorsTalk Interviews brings investors closer to the people behind listed companies, markets and sectors. We feature interviews with CEOs from UK, US and Canadian companies, alongside fund managers, analysts and sector specialists, giving audiences direct insight into strategy, performance, opportunities and risks. Each interview is designed to help investors understand the businesses shaping the market and make more informed decisions.

Applied Graphene Materials take huge step forward with mainstream product launches

Applied Graphene Materials (LON: AGM) CEO Adrian Potts joins DirectorsTalk to discuss product launches in both Halfords and on Amazon.com. Adrian explains what this means for the company, developments to..

Genedrive – Acceleration of news flow expected

Genedrive plc (LON: GDR) is the topic of conversation when Dr Dorothea Hill joins DirectorsTalk. After releasing a note anticipating accelerated news flow from Genedrive Dorothea gives us an update..

SmartSpace Increased Sales and Demand that’s not slowing down

SmartSpace Software plc (LON: SMRT) CEO Frank Beechinor joins DirectorsTalk to discuss interim results, acquisition and placing. Frank talks us through the interim highlights, provides background and rationale behind the..

Volta Finance 9%+ yield in uncertain times

Volta Finance Limited (LON: VTAS) is the topic of conversation when Mark Thomas joins DirectorsTalk. Mark explains why the report is sat behind a disclaimer, talks us through his note,..

Why Nanoco Group – Leaders in Quantum dot technology are bullish on the future

Nanoco Group plc (LON: NANO) CEO Michael Edelman joins DirectorsTalk to discuss highlights of the financial year end, the new market of IR sensing, the US customer, optimism in the..

Inchcape PLC significant resources for investment or shareholder returns

Inchcape PLC (LON: INCH) is the topic of conversation when Mike Allen, Head of Research at Zeus Capital talks to DirectorsTalk. Mike explains when he has recently published a new..

Avacta plc Major opportunity with Pro-doxorubicin will be the first of many

Avacta plc (LON: AVCT) CEO Alastair Smith joins DirectorsTalk to discuss an agreement with ADC therapeutics. Alastair talks us through the agreement, explains what is expected from AVA6000 pro-doxorubicin in..

Tatton Asset Management Good organic growth & better than market appreciation

Tatton Asset Management (LON: TAM) is the topic of conversation when Robin Savage, Analyst at Zeus Capital joins DirectorsTalk. Robin reminds us of the services the company provides, talks us..

Applied Graphene Materials Commercial momentum continues to build – CEO Interview

Applied Graphene Materials (LON: AGM) CEO Adrian Potts joins DirectorsTalk to discuss its full year results for the year ended 31st July 2019. Adrian explains the highlights for the year,..

Vordere Excited with Brazilian Acquisition

Vordere plc (LON: VOR) CEO Nicholas Hofgren joins DirectorsTalk to discuss its latest acquisition in Brazil. Nicholas runs us through the company business model, explains what the acquisition means for..

Sativa Group take an important step forward with controlled drug licence

Sativa Group (NEX: SATI) CEO Henry Lees-Buckley joins DirectorsTalk to discuss the award of a Controlled Drug Licence from the UK Home Office. Henry explains why this is an important..

Why Metal Tiger could be worth 78% more than current pricing

Metal Tiger plc (LON: MTR) is the topic of conversation when Jason Robertson, Analyst at First Equity joins DirectorsTalk. Jason explains why he’s set a target price of 2.5p per..

ANALYST INTERVIEW: Why City of London Investment Group will continue to deliver

City of London Investment Group (LON: CLIG) is the topic of conversation when Robin Savage, Analyst at Zeus Capital joins DirectorsTalk. Robin talks us through the key points from the..

ANALYST INTERVIEW: Vertu Motors ‘In deep value territory’ – Zeus Capital

Vertu Motors (LON: VTU) is the topic of conversation when Mike Allen, Head of Research at Zeus Capital joins DirectorsTalk. Mike talks us through the results any key themes he..

ANALYST INTERVIEW: RM SECURED DIRECT LENDING ‘Defensive qualities in uncertain times’

RM Secured Direct Lending (LON: RMDL) is the topic of conversation when Mark Thomas, Analyst at Hardman & Co joins DirectorsTalk. Mark talks us through the conclusions of his report..

CEO INTERVIEW: Zoetic International Significant developments & improvements through H1

Zoetic International plc (LON: ZOE), the London listed vertically integrated CBD and natural resources company, has today provided the following trading update in respect of the six month period ended..

ANALYST INTERVIEW: Ilika plc in a very good position right now – Baden Hill

Ilika plc (LON: IKA) is the topic of conversation when DirectorsTalk caught up with Baden Hill partner and Clean Tech Equity Specialist Dr Tom McColm. Tom provides his take on..

ANALYST INTERVIEW: Strix Group Valuation metrics look attractive – Zeus Capital

Strix Group plc (LON: KETL) is the topic of conversation when Andy Hanson, Analyst at Zeus Capital joins DirectorsTalk. Andy talks us through the key highlights from the company’s interim..

ANALYST INTERVIEW: Ilika Well positioned for a $100bn industry – Liberum

Ilika plc (LON: IKA) is the topic of conversation when Adam Collins, Equity Research Analyst at Liberum joins DirectorsTalk. Adam reminds us of the partnerships has established for Electric Vehicles,..

CEO INTERVIEW: Universe Group well positioned for growth in 2019 and beyond

Universe Group (LON: UNG) CEO Jeremy Lewis talks to DirectorsTalk about its interim results for the six months to 30th June 2019. Jeremy talks us through the highlights, provides some..

Search

Funds

Interviews

Search

Funds

Interviews

FTSE 100

Funds